Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Latest Articles

  • Open Access
    SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy
    AHMED ADHAM RAAFAT ELSAYED, SARMAD AL-MARSOUMMI, EMILIE E. VOMHOF-DEKREY and MARC D. BASSON
    Cancer Genomics & Proteomics May 2022, 19 (3) 328-338; DOI: https://doi.org/10.21873/cgp.20323
  • Open Access
    Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer
    MÁRK HÍVEŠ, JANA JUREČEKOVÁ, JÁN KLIMENT, MARIÁN GRENDÁR, PETER KAPLÁN, RÓBERT DUŠENKA, DANIEL EVIN, MARTA VILČKOVÁ, KLAUDIA HÍVEŠ HOLEČKOVÁ and MONIKA KMEŤOVÁ SIVOŇOVÁ
    Cancer Genomics & Proteomics May 2022, 19 (3) 362-371; DOI: https://doi.org/10.21873/cgp.20326
  • Open Access
    Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts
    ANNA SANCHEZ, FRÉDÉRIQUE PENAULT-LLORCA, YVES-JEAN BIGNON, LAURENT GUY and DOMINIQUE BERNARD-GALLON
    Cancer Genomics & Proteomics May 2022, 19 (3) 339-349; DOI: https://doi.org/10.21873/cgp.20324
  • Open Access
    Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma
    ULRICH H. WEIDLE, TATJANA SELA, ULRICH BRINKMANN and JENS NIEWOEHNER
    Cancer Genomics & Proteomics May 2022, 19 (3) 283-298; DOI: https://doi.org/10.21873/cgp.20320
  • Open Access
    Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions
    MICHELE MASSIMINO, STEFANIA STELLA, GIOVANNI MICALE, LUCIA MOTTA, GIULIANA PAVONE, GIUSEPPE BROGGI, ELIANA PIOMBINO, GAETANO MAGRO, HECTOR JOSE SOTO PARRA, LIVIA MANZELLA and PAOLO VIGNERI
    Cancer Genomics & Proteomics May 2022, 19 (3) 350-361; DOI: https://doi.org/10.21873/cgp.20325
  • Open Access
    Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma
    SIMONE O. HEYLIGER, KARAM F.A. SOLIMAN, MARILYN D. SAULSBURY and R. RENEE REAMS
    Cancer Genomics & Proteomics May 2022, 19 (3) 305-327; DOI: https://doi.org/10.21873/cgp.20322
  • Open Access
    Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase
    YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics May 2022, 19 (3) 299-304; DOI: https://doi.org/10.21873/cgp.20321
  • You have access
    Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study
    ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA and MILOS PESEK
    Cancer Genomics & Proteomics March 2022, 19 (2) 270-281; DOI: https://doi.org/10.21873/cgp.20319
  • You have access
    Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature
    MAGNUS BERLE, KJERSTI E. HESTETUN, HEIDRUN VETHE, SIMONA CHERA, JOAO A. PAULO, OLAV DAHL and METTE PERNILLE MYKLEBUST
    Cancer Genomics & Proteomics March 2022, 19 (2) 130-144; DOI: https://doi.org/10.21873/cgp.20309
  • You have access
    MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer
    METTE PERNILLE MYKLEBUST, ANNE METTE SØVIKNES, OLE JOHAN HALVORSEN, ANNA THOR, OLAV DAHL and HELGE RÆDER
    Cancer Genomics & Proteomics March 2022, 19 (2) 178-193; DOI: https://doi.org/10.21873/cgp.20313

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 81
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire